Gilead, Cognizant
Cognizant Expands Partnership with Gilead
Gilead is expected to enhance its efficiency through leveraging Cognizant’s expertise in AI and advanced technology applications. By deploying these solutions across the value chain, Cognizant aims to help Gilead achieve significant benefits through a newly optimized financial framework.
Gilead Sciences, Inc. (NASDAQ:GILD) develops and markets medicines for HIV, COVID-19, hepatitis, cancer, and other serious conditions. On January 30, Gilead Sciences ...
Gilead Sciences (GILD) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback